• Join
  • Login
  • Contact

Search abstracts

A glance on current progress of innovative drug R&D in china

  • At: PSWC, Melbourne (Australia) (2014)
  • Type: Presentation
  • By: SANG, Guowei (Chinese Pharmaceutical Association, Beijing, China)
  • Abstract:

    Prior to the China 10th 5-Year Plan (2001-2005), the most of Chinese pharmaceutical companies basically only focused on the generic drug development as only a few of them are affordable and willing to invest on innovative drug development. With the new national policy on Innovation Society promulgated by the State Council since 2005, the


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses